Welcome to our dedicated page for Cannabis Suisse news (Ticker: CSUI), a resource for investors and traders seeking the latest updates and insights on Cannabis Suisse stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cannabis Suisse's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cannabis Suisse's position in the market.
Cannabis Suisse Corp. (OTC PINK:CSUI) announced the launch of its Swiss4Life TerpX3, a new CBD tincture designed for anti-inflammatory and pain relief, plus anti-stress effects. The product, which contains 1000mg of CBD per bottle with 0% THC, will be available on Shopify. This expansion into online sales aims to enhance access to US markets. Made from USA-grown hemp, the product will be manufactured by Silver Shadow Ventures, ensuring high-quality production and compliance. The press release also highlights the therapeutic terpenes and their potential health benefits.
Cannabis Suisse Corp. (OTC PINK:CSUI) has launched its Swiss4Life TerpX2 CBD tincture, containing 1000mg CBD per 30ml bottle, aimed at enhancing consumer wellness. The product is THC-free, infused with high-quality hemp seed oil, and designed for precise dosing with graduated droppers. Swiss4Life TerpX2 offers anti-inflammatory, pain relief, and focus benefits derived from its terpenes, including limonene and camphor. Manufactured in the USA under FDA guidelines, the product is set to be available on Shopify. It is not designated for medical use and has not been evaluated by the FDA.
Cannabis Suisse Corp. (CSUI) has announced the launch of its new CBD product line, Swiss4Life, set to debut on Shopify. The first product is a 30ml Broad Spectrum Oil available in Crème de Menthe and Cherry Vanilla flavors, with CBD concentrations of 1500 mg, 2500 mg, and 3500 mg. The oil is THC-free and uses high-quality hemp seed oil. Manufactured by Silver Shadow Ventures, the products are FDA registered and tested by independent labs, although they are not FDA-evaluated for medical use. This initiative aligns with the company's mission to enhance customer quality of life.
Cannabis Suisse Corp. (OTC PINK:CSUI) has partnered with Silver Shadow Ventures, LLC, an FDA Registered Entity, to manufacture a new line of high-quality CBD products. This collaboration aims to enhance the launch of their retail brand, focusing on quality assurance through rigorous QC testing and compliance with regulations. COO Alain Parrik emphasized the commitment to customer health and the planned introduction of therapeutic products. The first batch is expected by the end of October 2020.
Cannabis Suisse Corp. (OTC PINK:CSUI) is expanding its online presence with plans to launch a new retail brand for CBD products, alongside developing an online store on the Shopify platform. This initiative aims to penetrate the US market and extend beyond Europe. The company emphasizes quality, planning to collaborate with a certified manufacturer in the US and conduct independent lab testing on products. COO Alain Parrik highlights a significant 176% increase in US online CBD orders during spring and summer, showcasing promising market potential.
Cannabis Suisse Corp. (OTC: CSUI) announces plans to expand its online presence through a partnership with Amazon, launching a new line of hemp-based products, including hemp oil and gummies. This initiative aims to enhance access to US markets as the legal landscape for CBD products evolves. The company remains compliant with Amazon's regulations, focusing on hemp products since CBD is currently prohibited on the platform. COO Alain Parrik emphasizes that Amazon is a crucial distribution channel as they grow their online retail strategy.
Cannabis Suisse Corp. (CSUI) has entered negotiations with uWeed, a Swiss cannabis distributor, to strengthen its market position. uWeed, established in 2017, capitalizes on Switzerland's lenient THC regulations, enhancing product potency. With a commitment to quality, Cannabis Suisse aims to leverage uWeed's reputation for excellent customer service and diverse payment options, including a loyalty system. This partnership could enhance revenue and brand visibility in Switzerland and potentially throughout Europe. The outcome of these negotiations will be revealed by October 2020.
Cannabis Suisse is launching a new service called Your Cannabis Grow for customers in Europe, enabling them to grow cannabis seedlings in Swiss indoor farms. Customers can monitor their plants' growth via live video and receive their harvest in anonymous packages. The service, priced at 120 CHF, includes various benefits such as cloning, regular updates, and a certificate of ownership. While this service supports cannabis enthusiasts, it also addresses regulatory frameworks in Switzerland, where cannabis cultivation for recreational use is legal.